Pangea provides services to Pharma/Biotech companies based on its proprietary platform

Pangea’s platform provides our collaborators a boost in the drug development process, both at the research and clinical levels.

We are currently providing services focused on three goals:

Development of new synthetic lethal-based cancer drugs by identification of new molecular targets.

Patient stratification for targeted therapy.

Prediction of mode of resistance for available therapies.